Return to QS91 Overview

Prostate cancer [QS91]

Measuring the use of this guidance

Statement: 1

Men with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist

Quality standard measure: Proportion of men with prostate cancer who have a recorded discussion about treatment options and adverse effects with a named nurse specialist
What was measured: Percentage of trusts in England that provide prostate cancer services that have clinical nurse specialists in oncology available
Data collection end: March 2014
46%
Area covered: England and Wales
Source: Royal College of Surgeons National prostate cancer audit

Quality standard measure: Proportion of men with prostate cancer who have a recorded discussion about treatment options and adverse effects with a named nurse specialist
What was measured: Proportion of prostate cancer patients who reported that they were given the name of a Clinical Nurse Specialist who would support them through their treatment.
Data collection end: June 2015
85.6%
Data collection end: June 2016
84.9%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.

Quality standard measure: Evidence of local arrangements to ensure that men with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.
What was measured: Proportion of prostate cancer patients who reported that they were given the name of a Clinical Nurse Specialist who would be in charge of their care
Data collection end: November 2013
88%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.

Quality standard measure: Evidence of local arrangements to ensure that men with prostate cancer have a discussion about treatment options and adverse effects with a named nurse specialist.
What was measured: Proportion of prostate cancer patients who reported that they were given the name of a Clinical Nurse Specialist who would be in charge of their care
Data collection end: June 2016
84.9%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.



 Return to QS91 Overview